These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11193890

  • 1. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
    Knight V, Kleinerman ES, Waldrep JC, Giovanella BC, Gilbert BE, Koshkina NV.
    Ann N Y Acad Sci; 2000; 922():151-63. PubMed ID: 11193890
    [Abstract] [Full Text] [Related]

  • 2. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
    Koshkina NV, Kleinerman ES, Waidrep C, Jia SF, Worth LL, Gilbert BE, Knight V.
    Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
    [Abstract] [Full Text] [Related]

  • 3. Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice.
    Knight V, Koshkina NV, Waldrep JC, Giovanella BC, Gilbert BE.
    Cancer Chemother Pharmacol; 1999 Jul; 44(3):177-86. PubMed ID: 10453718
    [Abstract] [Full Text] [Related]

  • 4. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A, Waldrep JC, Densmore CL, Koshkina N, Melton S, Roberts L, Gilbert B, Knight V.
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.
    Verschraegen CF, Gilbert BE, Loyer E, Huaringa A, Walsh G, Newman RA, Knight V.
    Clin Cancer Res; 2004 Apr 01; 10(7):2319-26. PubMed ID: 15073107
    [Abstract] [Full Text] [Related]

  • 9. Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.
    Zamboni WC, Jung LL, Egorin MJ, Potter DM, Friedland DM, Belani CP, Agarwala SS, Wong MM, Fakih M, Trump DL, Jin R, Strychor S, Vozniak M, Troetschel M, Ramanathan RK.
    Clin Cancer Res; 2004 Aug 01; 10(15):5058-64. PubMed ID: 15297407
    [Abstract] [Full Text] [Related]

  • 10. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
    Pantazis P, Han Z, Balan K, Wang Y, Wyche JH.
    Anticancer Res; 2003 Aug 01; 23(5A):3623-38. PubMed ID: 14666658
    [Abstract] [Full Text] [Related]

  • 11. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
    Pantazis P, Early JA, Kozielski AJ, Mendoza JT, Hinz HR, Giovanella BC.
    Cancer Res; 1993 Apr 01; 53(7):1577-82. PubMed ID: 8453626
    [Abstract] [Full Text] [Related]

  • 12. Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
    Zamboni WC, Strychor S, Joseph E, Parise RA, Egorin MJ, Eiseman JL.
    Cancer Chemother Pharmacol; 2008 Aug 01; 62(3):417-26. PubMed ID: 17957368
    [Abstract] [Full Text] [Related]

  • 13. Structure-activity relationship of alkyl 9-nitrocamptothecin esters.
    Cao ZS, Pantazis P, Mendoza J, Early J, Kozielski A, Harris N, Giovanella B.
    Acta Pharmacol Sin; 2003 Feb 01; 24(2):109-19. PubMed ID: 12546717
    [Abstract] [Full Text] [Related]

  • 14. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, Bandyopadhyay A, Knight V, Gilbert BE, Sanders BG, Kline K.
    Cancer Chemother Pharmacol; 2004 Nov 01; 54(5):421-31. PubMed ID: 15197487
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
    Han Z, Wyche JH, Sands H, Pantazis P.
    Anticancer Res; 2001 Nov 01; 21(3B):1823-7. PubMed ID: 11497265
    [Abstract] [Full Text] [Related]

  • 20. 9-Nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro.
    Pantazis P, Mendoza JT, Early JA, Kozielski AJ, Natelson EA, Giovanella BC.
    Eur J Haematol; 1993 Feb 01; 50(2):81-9. PubMed ID: 8440362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.